Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
19 December 2017 10:13
Around 7,400 British women are diagnosed with ovarian cancer each year
A breakthrough ovarian cancer treatment has been launched in Britain, with the potential to prolong patients' lives and hold back the cancer - reducing relapse times.
The once-a-day pill, named Niraparib, is part of a new class of drugs that target cancers with defective DNA repair systems.
New hope for patients
This latest trial shows Niraparib can massively increase the length of time before cancer returns following chemotherapy.
Results show that for some women - those with an inherited BRCA gene mutation - the length of time before reoccurrence increased from five and a half months to 21 months, when compared with patients undergoing chemotherapy treatment alone.
The study also shows that women without the BRCA mutation benefit from the drug, experiencing double their relapse times.
"Niraparib is the first treatment of its class licensed to delay the progression of ovarian cancer following platinum-based chemotherapy, regardless of BRCA status," says Professor Jonathan Ledermann, from the University College London Cancer Institute.
He continued: "This represents a critical milestone in the management of ovarian cancer. Access to effective and tolerable medicines is sorely needed and the hope is that niraparib will be available in the NHS as quickly as possible."
'Nationwide roll-out'
Around 7,400 women are diagnosed with ovarian cancer each year in Britain, with around 85% of patients seeing it reoccur after treatment.
The cost of the treatment and benefits to the patients are weighed up by the National Institute for Health and Care Excellence (Nice) in England and Wales and the Scottish Medicines Consortium in Scotland.
Katherine Taylor, chief executive of the charity Ovarian Cancer Action, said: "Today's news is an encouraging step in the right direction but we now need to ensure all UK women diagnosed with recurrent platinum-sensitive ovarian cancer can benefit.
"We call upon the National Institute for Health and Care Excellence and the Scottish Medicines Consortium to approve this drug to provide more treatment options for those diagnosed with ovarian cancer - for many women this could be life changing."
Whatever stage your cancer is at, we may still be able to cover you for holidays and overseas travel with our specialist cancer travel insurance.
20 July 2018
Computer problems have hit British Airways operations at London's Heathrow Airport.
[more...]
19 July 2018
The flu vaccination does not appear to have been effective in protecting against so-called Aussie flu, figures show.
18 July 2018
Bowel cancer screening tests could also provide an insight into whether patients are at risk of other illnesses, a new study has revealed.
17 July 2018
France is still celebrating today after its national football team brought home football's biggest prize after a thrilling final in Moscow.
14 July 2018
Too many passengers heading abroad this summer will be travelling without adequate protection for when an airline goes bust, a new study has shown.
13 July 2018
The mother of Bradley Lowery has welcomed the news that a drug used to help treat her son will soon be made available for other patients on the NHS.
12 July 2018
British GPs have prevented thousands of strokes after learning how to better identify and treat a common heart condition, research has shown.
11 July 2018
London City Airport is considering lodging an application to increase flight and passenger numbers, its boss has revealed.
10 July 2018
Captain Harry Kane is leading England's unexpected bid for glory, and is hoping to inspire the next generation of footballers by going all the way in Russia.
07 July 2018
Experts have warned that a lack of rigorous testing of skin cancer detection apps is putting the public at risk.
06 July 2018
Easyjet has added to worries that travellers are set for a summer of chaos, revealing that nearly 1,300 flights were cancelled last month.
05 July 2018
Soaring temperatures across the UK have led to a surge of asthma sufferers calling a dedicated asthma helpline, a charity has revealed.